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Abstract
Allelic variation at the 3P-end of the vitamin D receptor (VDR) gene has been associated with a 3^5-fold increased risk of
developing prostate cancer and with differences in bone mineralization. This genetic diversity does not alter the VDR protein
structurally, but instead may be a marker(s) of other, nearby polymorphisms that influence message stability or translation.
The work reported here was instigated to identify additional VDR 3P-UTR polymorphisms that may have functional
significance and to then test whether these genetic variants alter message stability. Initially, four novel, frequently occurring
sequence variants were identified that associated with two common haplotypes that were described previously. These
common sequence variants were not found within three message-destabilizing elements that we mapped within the 3P-UTR of
the vitamin D receptor mRNA. Furthermore, the two VDR 3P-UTR haplotypes conferred an identical half-life on a
heterologous L-globin reporter gene, in an in vitro assay. We therefore conclude that common polymorphisms within the
VDR 3P-UTR do not influence message stability. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
The biologically active form of vitamin D, 1K,25-
dihydroxyvitamin D3, functions through a nuclear
receptor to regulate mineral homeostasis and bone
metabolism, as well as cellular di¡erentiation and
proliferation [1]. Recent studies have associated re-
striction fragment length polymorphisms (RFLPs) in
the 3P-region of the VDR gene with normal physio-
logical variability in circulating osteocalcin and vita-
min D levels and with di¡erences in bone minerali-
zation [2,3]. Three independent studies, by Taylor
et al. [4] and Ingles et al. [5,6], associated normal
genetic variation at the 3P-end of the vitamin D
receptor (VDR) gene with altered risk of prostate
cancer in Caucasian and African-American popula-
tions. RFLPs in intron 8 (BsmI, ApaI) and in exon 9
(TaqI) are in linkage disequilibrium with a poly(A)
microsatellite ((A)14ÿ17 = S (short), (A)18ÿ24 = L
(long)) in the VDR 3P-untranslated region (3P-
UTR) of Caucasians and de¢ne two common haplo-
types, BAt,S and baT,L (where b, a, and t are cut by
0925-4439 / 99 / $ ^ see front matter ß 1999 Elsevier Science B.V. All rights reserved.
PII: S 0 9 2 5 - 4 4 3 9 ( 9 9 ) 0 0 0 0 7 - 1
* Corresponding author. Fax: +1 (323) 865-0634;
E-mail : coetzee_g@froggy.hsc.usc.edu
BBADIS 61816 22-3-99
Biochimica et Biophysica Acta 1453 (1999) 311^320
BsmI, ApaI, and TaqI, respectively, while B, A, and
T are not cut). Taylor’s study [4] focused on a TaqI
RFLP in exon 9 (codon 352) that did not change the
protein sequence of the VDR. Men who were homo-
zygous for the TaqI RFLP (genotype tt) had a one-
third decreased risk of prostate cancer than did men
who were either homo- or heterozygous for the T
allele (genotype Tt or TT). In analogous studies, In-
gles et al. [5,6] examined the poly(A) length polymor-
phism in the 3P-UTR and found that Caucasian men
who harbored either one or two L alleles (LL or LS)
had a 4^5-fold increased risk of prostate cancer than
did individuals homozygous for the short allele (SS).
Among African-American men, only weak linkage
disequilibrium exists between the BsmI and poly(A)
microsatellite markers [8]. However, a haplotype
(BL) was identi¢ed in this ethnic group that con-
ferred prostate cancer risk [6]. The one common fea-
ture of the ‘at risk’ allele in the two ethnic groups
was the long (L) microsatellite in the 3P-UTR. Allelic
di¡erences (including possibly the size di¡erence of
the microsatellite) in the 3P-UTR of the VDR may
a¡ect message translation or stability. A decreased
abundance of the vitamin D receptor could then
lead to reduced tissue responsiveness to 1K,25-dihy-
droxyvitamin D3 and increased risk of prostate can-
cer.
Several recent papers have examined di¡erences in
the function of two primary polymorphic forms of
VDR. Verbeek et al. [9] and Mocharla et al. [10] used
the reverse transcriptase-polymerase chain reaction
(RT-PCR) assay to measure the abundance of the
mRNAs from two di¡erent VDR genotypes in nor-
mal lymphocytes, and in leukemia and prostate car-
cinoma cell lines. Mocharla et al. [10] reported no
di¡erence in the amount of mRNA transcribed
from either BsmI allele (B or b) in cells that were
homo- and heterozygous at this locus. Conversely,
Verbeek et al. [9] consistently detected about 30%
fewer transcripts from the TaqI (t) allele than from
the T allele. They observed no di¡erence, however, in
the half-life of these two polymorphic transcripts. In
an independent study, Carling et al. [11] employed
the ribonuclease protection assay to measure signi¢-
cantly lower VDR message levels in parathyroid ad-
enomas of patients who were homozygous for the b,
a, T, or baT alleles than in patients who were homo-
zygous for the B, A, t, or BAt genotype. Finally,
Gross et al. [12] did not detect any variation in mes-
sage levels when examining the BsmI alleles (B vs. b)
in heterozygous (Bb) ¢broblasts. The latter group
also examined expression from BsmI B and b alleles,
and cellular responsiveness to 1K,25-dihydroxyvita-
min D3, in dermal ¢broblasts. They noted no signi¢-
cant di¡erences in protein function between alleles.
The BB and bb cell lines used by this group, how-
ever, included a variety of genotypes at the ApaI and
TaqI polymorphic sites downstream of BsmI. Thus,
it cannot be presumed that the BsmI genotype is
indicative of polymorphic sites further downstream
in the 3P-UTR.
Concurrently with the studies referred to above,
we set out to examine mRNA stability bestowed by
VDR 3P-UTRs of known sequence in order to estab-
lish the mechanism whereby normal allelic variation
in the VDR gene may lead to a modi¢ed physiolog-
ical response that can alter prostate cancer risk. The
rationale for these experiments is two-fold. First, it is
well known that the 3P-UTR is a major regulator of
message half-life [13]. Second, areas of linkage dise-
quilibrium do not extend very far along the s 70-kb
VDR gene, in the populations in which the associa-
tions with prostate cancer risk were demonstrated.
For example, a FokI RFLP in the VDR translation
initiation site is not in linkage disequilibrium with
the 3P-polymorphisms [14,15] and even the 3P-BsmI
and poly(A)n variants (which are separated by only 3
kb of sequence) are not tightly linked in all ethnic
groups [8]. Initially, we sequenced the VDR 3P-UTR
from eight individuals in order to detect frequent
polymorphisms associated with the poly(A) microsa-
tellite haplotypes. Two common VDR alleles were
then inserted into a reporter plasmid, downstream
of the stable rabbit L-globin gene that was under
transcriptional control of the c-fos promoter. This
reporter plasmid has been used extensively to meas-
ure the half-life conferred by a heterologous 3P-UTR.
We were thus able to measure directly whether allelic
di¡erences in the VDR 3P-UTR encoded di¡erences
in message stability. In concurrent work, we identi-
¢ed three redundant, non-cooperative destabilizing
elements in the VDR 3P-UTR. None of these se-
quence elements included the common polymor-
phisms. Additionally, the rare sequence variants did
not alter message half-life conferred by nearby desta-
bilizing elements.
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2. Materials and methods
2.1. Detection of polymorphisms in the
VDR 3P-UTR
To identify polymorphisms within the vitamin D
receptor 3P-UTR, DNA was obtained from the leu-
kocytes of eight individuals. Five individuals had
previously been shown by genotype analysis to be
homozygous for an (A)18ÿ24 tract (L) and another
three individuals were homozygous for a (A)12ÿ17
tract (S). The entire 3.1 kb of 3P-non-coding sequen-
ces were ampli¢ed by the polymerase chain reaction
technique and sequenced, without prior insertion
into a vector. The frequency of a novel 5-nt insertion
(+AGCCC after nt 2517, see Section 3) was assessed
in an additional 25 African-Americans, 25 Asians,
25 Latinas, and 67 Caucasians.
2.2. Plasmid construction
The two relatively common polymorphic forms of
the VDR 3P-UTR were ampli¢ed from leukocyte
DNA and then inserted immediately after the rabbit
L-globin gene in the plasmid pBBB (kindly provided
by Ann-Bin Shyu [16]; by the following multi-step
procedure. First, the 3.1-kb of 3P-UTR DNA (from
immediately after the translation stop codon to, but
not including, the poly(A) addition site) was ampli-
¢ed by the polymerase chain reaction (PCR) techni-
que as two overlapping fragments. The primer pairs
used were F9/R6 (1547-bp product) and F2/R11
(2009-bp product) (Table 1). The two PCR products
were digested at a common NotI restriction enzyme
site, and with BglII (cuts adjacent to the primer se-
quences), and ligated together into the BglII site of
pBBB to give pVDR-3.1(L) and pVDR-3.1(S). The
integrity of all VDR sequences in pVDR-3.1(L) and
pVDR-3.1(S) was con¢rmed by dideoxynucleotide
sequencing using the ThermoSequenase kit (Amer-
sham).
Deletions were produced by digesting pVDR-
3.1(L) with unique cutting restriction enzymes or
by amplifying speci¢c DNA fragments with primer
pairs (Table 1; also see Fig. 4, top). Constructs de-
leted of their 3P-sequences initiated at the SmaI site
(except for one that started immediately after the
translation termination signal (TGA) and which
was designated with an asterisk) and were denoted
by an L and a number. The number represents the
last nucleotide, before the deletion site, that is in-
cluded in the construct. Numbering begins after the
TGA. Constructs deleted of their 5P-sequences were
denoted by an R and a number that indicates the
initiating nucleotide. All these latter constructs ter-
minate at a common 3P-end point, immediately up-
stream of the poly(A)-addition site. Other constructs
were prepared by PCR ampli¢cation of speci¢c
DNAs. All VDR sequences within the plasmid con-
structs were validated by dideoxynucleotide sequenc-
ing as described above.
Plasmid pGAPM was kindly provided by Greg
Goodall [17]. The plasmid pTRIamp-L-globin was
prepared by digesting pBBB with PstI after which
the end was ¢lled in with T4 DNA polymerase.
The plasmid was then digested with BamHI and
the 835-bp L-globin fragment was ligated into the
SmaI/BamHI sites of the vector pTRIamp19 (Am-
bion).
2.3. Cell culture and transfections
Mouse NIH3T3 cells were maintained in Dulbec-
co’s modi¢ed Eagle’s medium (DMEM) with 10%
fetal bovine serum (FBS). Cells were plated to ap-
proximately 50% con£uence on 60 mm dishes, grown
overnight and then transfected using the liposome
transfection methodology. Brie£y, 3 Wg of the exper-
imental DNA (pBBB-X) was combined with 1 Wg of
pCDNEO in 150 Wl of serum-free DMEM (DMEM-s/
f). This mixture was added to an equal volume of
DMEM-s/f containing 10^12 Wl of TransfectAMINE
reagent (Life Technologies) and DNA^liposome
complexes were allowed to form for 30 min at
room temperature. The complexes were then diluted
to 1.5 ml total with DMEM-s/f and added to a plate
of NIH3T3 cells that had been washed once with
DMEM-s/f. After 5 h at 37‡C, 5% CO2, the DNA^
liposome mixture was removed and the cells were
grown in DMEM^10% FBS and incubated as above
for 2 days. Cells were then trypsinized and replated
on two to four 100-mm plates in DMEM^10% FBS
containing 300 Wg/ml geneticin (G418-sulfate; Life
Technologies). Colonies (100^300) were pooled after
12^14 days and maintained in DMEM^10% FBS
plus 200 Wg/ml geneticin. For analysis of mRNA
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decay, cells were plated on 60-mm dishes, grown to
80^90% con£uence, then washed two times with
phosphate bu¡ered saline (PBS) and serum starved
in DMEM^0.5% FBS. After 24 h, the cells were
stimulated with DMEM^20% FBS for 0^8 h. Two
stably transfected cell lines were prepared from each
construct and message half-life was measured two
or three times for each cell line (four to six times
total).
2.4. RNA preparation and analysis of mRNA decay
Total RNA was isolated at speci¢c times after se-
rum stimulation, by the Purescript RNA isolation
method (Gentra Systems). Cells were washed once
with PBS and then lysed with cell lysis solution. Pro-
tein and DNA were precipitated and removed and
total RNA was recovered by isopropanol precipita-
tion. Transcripts derived from transfected DNA, and
cellular GAPDH, were detected by RNase protection
analysis using in vitro synthesized complementary
RNA probes. The pBBB, pVDR-3.1(S) and pVDR-
3.1(L) transcripts (L-globin or L-globin/vitamin D
receptor fusion mRNAs; Fig. 1) were detected using
probes synthesized from the plasmid pTRIampL-glo-
bin digested with NcoI, using T7 RNA polymerase
and 200 Ci/mmol of [K-32P]UTP. The 278 nucleotide
(nt) probe protected a 188-nt fragment within the
L-globin coding region. As an internal, loading con-
trol, a 120-nt fragment of the mouse GAPDH
mRNA was detected using a 175-nt riboprobe [17].
RNase protection assays were performed as de-
scribed by the manufacturer (Ambion), using 10 Wg
of total RNA. Protected products were analyzed on
6% polyacrylamide^8 M urea gels which were dried
prior to quanti¢cation. The amount of speci¢c
mRNA was measured by PhosphorImager analysis
using Imagequant version 3.21 (Molecular Dynam-
ics, Sunnyvale, CA) and normalized with respect to
the GAPDH internal standard. To correct for the
increase in GAPDH message levels during serum
stimulation, the GAPDH mRNA data for each
time point (approximately 50 independent values)
were pooled and a regression line was ¢tted to this
data to calculate the expected GAPDH message lev-
els. The L-globin mRNA levels were then normalized
to these expected GAPDH transcript levels.
3. Results
3.1. Polymorphisms in the 3P-UTR of the vitamin D
receptor message
The entire vitamin D receptor 3P-UTR was se-
quenced in order to identify genetic variations that
might regulate message stability. DNA was isolated
from the leukocytes of eight individuals who were
chosen on the basis of their genotype at the (A)n
microsatellite; ¢ve individuals were homozygous
‘long’ (L) and the other three were homozygous
‘short’ (S) at this site. The entire vitamin D receptor
3P-UTR from each test subject was ampli¢ed as a
series of overlapping fragments and sequenced man-
ually, using the dideoxynucleotide sequencing proto-
col of Sanger et al. [18], without prior subcloning.
This approach avoids erroneous identi¢cation of ei-
ther ampli¢cation or cloning artifacts. The method is
also sensitive enough to detect heterozygosity at in-
dividual nucleotides. We observed seven polymor-
phisms, four of which appeared to be common
(present in six (S) or ten (L) out of sixteen total
alleles sequenced) and three that were rare (see be-
low). In this limited study, the common sequence
Fig. 1. Polymorphisms within the vitamin D receptor 3P-UTR.
Two common haplotypes of the vitamin D receptor 3P-UTR
are shown schematically as a double line with the stippled box
at the left representing part of the coding region and TGA is
the VDR translation termination signal. The horizontal arrow
depicts a forward oriented Alu-like sequence. Sequences are
numbered at the top according to Baker et al. [19]. Genetic var-
iations are shown as those that associate most commonly with
the baT,L haplotype (top) or with the BAt,S haplotype (bot-
tom). Three polymorphisms that occur infrequently are shown
in brackets. Three destabilizing elements (see later) are depicted
as gray or black ¢lled boxes and designated as DE-I, DE-II
and DE-III at the bottom.
BBADIS 61816 22-3-99
L.K. Durrin et al. / Biochimica et Biophysica Acta 1453 (1999) 311^320314
variants associated exclusively with the L or S poly-
(A) tract (Fig. 1). The nucleotide location (relative to
the sequence of Baker et al. ; [19]), and the haplotype
the frequent polymorphisms associated with, are des-
ignated as C1588A, T2074del, C3185A, A3424T
(where the initial nucleotide was associated with the
L allele and the latter nucleotide was associated with
the S allele). Rare genetic variants were heterozygous
in the eight individuals examined and included a 5-nt
insertion (AGCCC2517del, found on about 7% of L
alleles among Caucasians and Latinas, but not
among African-Americans or Asians), and T2697C
and A4107G sequence conversions (where the C
and the G, respectively, were found once only in 16
alleles sequenced). The (A)n microsatellite centers
around nt 3400 (Fig. 1). In addition to the poly(A)
microsatellite, only one of these polymorphisms, the
T2074del, corresponded with any of the VDR se-
quence variants previously reported to di¡erentially
in£uence gene expression [3].
3.2. Half-life conferred by the polymorphic vitamin D
receptor 3P-UTRs
Calculation of mRNA decay rate following short-
term activation of an inducible promoter (i.e. the c-
fos promoter) is a widely used method to measure
message stability (Fig. 2) [16,17]. Degradation of the
L-globin gene, which is very stable when regulated by
its homologous 3P-UTR (t1=2s 18 h; see below) [20],
is often used as the reporter in these constructs. In-
sertion of a heterologous 3P-UTR after the L-globin
translation termination site signals the L-globin gene
to be degraded with the kinetics characteristic of the
substituted 3P-UTR. The two allelic forms of the vi-
tamin D receptor mRNA 3P-UTR were prepared as
described in Section 2 and inserted into the unique
BglII restriction enzyme site in the reporter plasmid
pBBB (Fig. 2). Fig. 3A illustrates the nucleotides that
di¡er between the two constructs: the top line repre-
sents the L allele and the bottom line the S allele.
Only the more frequent polymorphisms were in-
cluded in the constructs. After stable integration of
the chimeric molecules into mouse NIH3T3 cells, the
c-fos promoter was silenced by 24 h growth in media
containing low serum (0.5%) and then induced
by serum growth factors (MEM+20% FBS). A
synchronized pool of mRNA was synthesized (the
c-fos promoter shuts o¡ after 30^60 min [16,17]),
after which message degradation was measured.
Fig. 3B and C show representative autoradiograms
from ribonuclease protection assays that measured
the half-life (t1=2) of pBBB and pVDR-3.1(S). The
VDR message present at each time point was meas-
ured, corrected relative to the internal control
(GAPDH), and graphed (Fig. 3D). The VDR mes-
sage half-life was calculated from the linear descend-
ing slope. Both allelic forms of the VDR 3P-UTR
conferred almost identical half-lives on the heterolo-
gous L-globin gene (pVDR-3.1(L), t1=2 = 5.3 þ 1.4 h
and pVDR-3.1(S), t1=2 = 5.2 þ 0.4 h).
Table 1













R, reverse primers; F, forward primers. To facilitate localiza-
tion of primers on the VDR 3P-UTR, search GenBank with the
ascension number JO3258. Nucleotides depicted as small letters
are BglII restriction enzyme cutting sites used to facilitate clon-
ing into the reporter plasmid.
Fig. 2. Reporter vector pBBB [16]. Transcription of the rabbit
L-globin gene (¢lled boxes) is under control of the c-fos pro-
moter (open box at left). A unique BglII cloning site, for inser-
tion of heterologous 3P-UTR sequences, is located immediately
after the L-globin translation termination signal. The rabbit
L-globin poly(A) addition site (open box at right) encodes e⁄-
cient message termination and polyadenylation. The L-globin
gene coding region probe (exon 2) utilized for ribonuclease pro-
tection assays is illustrated (thick line, bottom).
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3.3. Destabilizing elements within the vitamin D
receptor 3P-UTR
To identify vitamin D receptor 3P-UTR functional
elements that regulate mRNA decay rates, a series of
3P-deleted DNA fragments were prepared by digest-
ing the pVDR-3.1(L) construct with the unique-cut-
ting restriction enzymes ApaI, SacI, KpnI, SphI, and
BamHI (Fig. 4, top; the translation termination sig-
nal (TGA) and a polymorphic Alu-like repeat se-
quence (arrow) are shown for reference). Half-lives
were measured as described in Section 2. Surpris-
ingly, the VDR 3P-UTR, deleted of anywhere from
400 to 1900 nt of its 3P-sequences (Fig. 4, constructs
L2689, L2337, L1702, L1219), still conferred a half-
life of approximately 4^5 h on the chimeric L-globin
message. This was similar to the half-life of the full-
length VDR 3P-UTR (pVDR-3.1(L), t1=2 = 5.3 þ 1.4
h). However, when another 500 nt was deleted, the
VDR 3P-UTR lost its ability to destabilize the L-glo-
bin message (Fig. 4, construct *L933, t1=2s 18 h).
Thus, a VDR destabilizing element ( = DE-I) was
located within the 500 nt delimited by the BamHI
and SphI restriction enzyme sites. This was con-
¢rmed by the 5P- and 3P-truncated construct 841^
1283, which encompassed only 442 nt of the VDR
non-coding sequences between the primer pair F7
and R3 (Table 1). These sequences destabilized the
L-globin message to t1=2 = 4.4 þ 0.4 h.
The Alu-like repeat element (Fig. 4, arrow) con-
tains the poly(A)n tract that has been associated
with prostate cancer risk [5,7]. This polymorphic
length allele, or other sequences in this vicinity, could
di¡erentially a¡ect stability of the VDR mRNA.
Thus, to further characterize these sequences, a
1150-bp region was ampli¢ed between the primer
pair F10 and R10 (Fig. 4, construct 1195^2342)
and inserted into pBBB. Interestingly, these sequen-
ces destabilized the L-globin message independent of,
and as e⁄ciently as did DE-I (t1=2 = 4.5 þ 1.1 h). To
further demarcate this second destabilizing element
(DE-II), the 1150-bp DNA sequence was dissected
into 710-bp (primer pair F10 and R12) and 480-bp
(primer pair F13 and R10) fragments and the half-
life conferred by these sequences was measured. The
smaller fragment (construct 1851^2342) included all
of the Alu-like repetitive element, but did not desta-
bilize the L-globin message (t1=2s 18 h). However,
Fig. 3. (A) Half-lives conferred by the VDR 3P-UTRs. The
plasmids pVDR-3.1(L) (top) or pVDR-3.1(S) (bottom) are iden-
tical except for the nucleotides indicated. These constructs were
transfected into NIH3T3 cells and half lives ( = t1=2) measured
as described in Section 2. All measurements were repeated 4^6
times. (B,C) Representative autoradiographs of ribonuclease
protection assays for pBBB and pVDR-3.1(S), respectively. (D)
The L-globin or L-globin-VDR fusion mRNA, at each time
point, was measured by PhosphorImage analysis and corrected
relative to the internal GAPDH loading control. Each time
point was plotted as a percentage of the maximum induced lev-
el of L-globin mRNA. Message half-life was calculated from
the descending slope. open circles, pBBB; ¢lled squares, pVDR-
3.1(L); ¢lled triangles, pVDR-3.1(S).
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the larger fragment (construct 1195^1897) did signal
L-globin mRNA destabilization (t1=2 = 3.8 þ 0.3 h).
Thus, DE-II was located adjacent to, but independ-
ent of, DE-I.
Deletions from the 5P-end of the VDR 3P-UTR
were prepared by restriction enzyme digestion at
the unique BamHI, NotI, KpnI or SacI sites and
also by PCR ampli¢cation. Interestingly, after dele-
tion of approximately 85% of the 5P-sequences (in-
cluding DE-I and DE-II), the remaining 430 nt of
sequences (delimited by the primer pair F12 and
R11) destabilized the L-globin message at a rate sim-
ilar to that of the full-length 3P-UTR (Fig. 4,
t1=2 = 3.8 þ 0.7 h for construct R2653). The singular-
ity of this element (DE-III), and its upstream border,
were con¢rmed by the 5P/3P-deletion construct 2292^
2689 (ampli¢ed using the primer pair F11 and R13)
which included approximately 400 nt of sequences
that did not direct L-globin message turnover
(t1=2s 18 h).
Interestingly, none of the common polymor-
phisms, including the (A)n tract, were situated within
the destabilizing elements. The rare sequence var-
iants, however, were either very near to or were with-
in the DNA fragments containing the three destabi-
lizing elements (summarized in Fig. 1).
Fig. 4. Half-lives of vitamin D receptor 3P-UTR deletion constructs. At the top is a schematic diagram of the vitamin D receptor 3P-
UTR depicting the translation termination signal (TGA), the variable length poly(A)n tract within the Alu-like repeat sequence (hori-
zontal arrow), and unique restriction enzyme cutting sites. The three destabilizing elements (DEs) identi¢ed by deletion analysis are
shown as gray or black ¢lled boxes. The lines at the bottom represent DNA sequences that are present in the constructs. Construct
names are shown at the left and half-lives (t1=2) conferred on the heterologous reporter gene are shown at the right.
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3.4. E¡ects of individual polymorphisms on message
stability
To compare whether speci¢c sequence variations
altered message stability, constructs were prepared
containing the alternative polymorphic form of indi-
vidual DEs (all constructs in Fig. 4 are either the L
or the common allele). The function of DE-I was not
signi¢cantly altered when either sequence variant was
present at T2074del (construct 724^1283, t1=2 =
4.6 þ 0.8 h (+T) vs. t1=2 = 3.6 þ 0.6 h (del), or at
AGCCC2517del (construct 841^1283, t1=2 = 4.4 þ
0.4 h (del) vs. t1=2 = 4.1 þ 0.7 h (+AGCCC). Likewise,
DE-II (construct 1195^2342) displayed similar t1=2
values when three sites (C3185A, (A)193400(A)14,
A3424T) were altered simultaneously (t1=2 = 4.5 þ
1.1 h (L) vs. 3.9 þ 1.7 h (S)). DE-III (construct
R2653) conferred similar half-lives when position
4107 was substituted with an A (t1=2 = 3.8 þ 0.7 h)
or a G (t1=2 = 4.2 þ 0.5 h). We have not yet investi-
gated whether AGCCC2517del or T2697C in£uence
the function of DE-II.
4. Discussion
Restriction fragment length polymorphisms (BsmI,
TaqI, and ApaI) and a variable length (A)n micro-
satellite (short (S) = A13ÿ17 ; long (L) = A18ÿ24) in the
3P-portion of the vitamin D receptor gene have been
associated with variability in prostate cancer risk and
with physiological di¡erences in bone density [2,4^6].
Additionally, 3P-UTR sequence di¡erences in two
common VDR haplotypes (baT,L and BAt,S) have
been associated with a small variability (less than
two-fold) in VDR gene expression [3]. The genetic
di¡erences in the latter study were detected after
comparing only two VDR alleles and may not rep-
resent true polymorphisms. Here we identi¢ed seven
novel sequence variants in the VDR 3P-UTR. Inter-
estingly, only one of these, T2074del (and also the
poly(A) tract described previously), corresponded
with the genetic variants previously reported to dif-
ferentially regulate gene expression [3]. These dis-
crepant results are likely due either to di¡erences in
methodology, or to di¡erences in the source of the
alleles sequenced. Incorrect nucleotides can be mis-
incorporated during PCR ampli¢cation of a DNA
fragment, even when using high-¢delity enzymes
such as rTth polymerase (personal observation). De-
tection of such incorrect nucleotides will be selected
for if the PCR products are then cloned into a vector
before sequencing.
Allelic variation in the 3P-UTR of a messenger
RNA could a¡ect a number of post-transcriptional
processes including message stability. We chose the
‘short-term promoter activation’ technique to exam-
ine whether known nucleotide di¡erences in the
VDR 3P-UTR conferred di¡erent half-lives on a het-
erologous L-globin reporter gene. We found that the
two variant 3P-non-coding regions signaled almost
identical rates of message degradation (Fig. 3A^D;
pVDR-3.1(L), t1=2 = 5.3 þ 1.4 h vs. pVDR-3.1(S),
t1=2 = 5.2 þ 0.4 h). Thus, it appears that common ge-
netic variation in the long VDR 3P-UTR does not
contribute to disease states by directly altering mes-
sage stability (and therefore abundance of the
mRNA). This conclusion is supported by the identi-
¢cation of three distinct destabilizing elements within
this region. These elements function in a non-addi-
tive, redundant, and sequence locality-independent
fashion (i.e. the distance between the translation ter-
mination site and the DE does not alter its destabi-
lizing abilities). Thus, in the mouse NIH3T3 cell sys-
tem, it appears that all three elements would have to
be altered for message half-life to be changed signi¢-
cantly. This is signi¢cant since none of the common
polymorphisms we identi¢ed were situated within the
DEs (Fig. 1) and the rare sequence variants did not
a¡ect message stability conferred by individual DEs
under our experimental conditions (see Section 3).
However, we suggest that the three VDR destabiliz-
ing elements may not always function contempora-
neously to constitutively destabilize messenger RNA.
An alternative hypothesis is that an individual DE
could moderate VDR message stability, independent
of the other two DEs, during di¡erentiation, devel-
opment and/or hormonal (e¡ector) stimulation.
Thus, a polymorphism within or adjacent to a DE
might modulate the activity of that functionally rel-
evant DE only in a speci¢c tissue (e.g. normal pros-
tate epithelial cells) or during a speci¢c stage of
growth or e¡ector stimulation. In support of this
premise, a recent example from another system has
demonstrated that, under hypoxic conditions, a pro-
tein is induced that binds one of two (normally de-
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stabilizing) AREs (message stability elements) within
the vascular endothelial growth factor gene 3P-UTR,
resulting in message stabilization [21]. Additionally, a
sequence element (105 bp) in the glucose transporter
(GLUT1) mRNA 3P-non-coding region mediates
message destabilization but can also function as a
site through which the cytokine, tumor necrosis fac-
tor-K stabilizes the message 5-fold [22].
As an alternative to regulating message stability,
it is possible that the VDR 3P-UTR interacts with
other, upstream sequences to regulate transcription,
translation, or RNA processing. A recently identi¢ed
translation initiation site RFLP (FokI), which is not
linked to the 3P-VDR polymorphisms, encodes two
di¡erent sized proteins and has been associated with
di¡erences in bone mineralization [14,15]. It is possi-
ble that a polymorphic functional element in the
VDR 3P-UTR interacts diversely with these two
translation start sites, leading to di¡erences in
VDR levels and, subsequently to changes in prostate
cancer risk and in bone mineralization. However, the
recent work by Mocharla et al. [10] and Gross et al.
[12] suggests that this may not be the case. Both
groups used RT-PCR to measure transcription
from two polymorphic forms of the VDR in homo-
zygous or heterozygous cell systems (normal lympho-
cytes, leukemia, and prostate carcinoma cells). They
noted neither allele-speci¢c di¡erences in message
levels nor di¡erences in protein abundance or func-
tion. One problem with these studies, however, is
that the genotype upstream and downstream of the
BsmI and TaqI RFLPs is not known and this could
signi¢cantly e¡ect interpretation of the results. Con-
versely, Carling et al. [11] did measure allelic di¡er-
ences in VDR message levels in parathyroid adeno-
mas. Thus, genetic diversity may exert tissue-speci¢c
di¡erences on VDR transcription.
Another possible explanation for the association
between genetic variation in the vitamin D receptor
3P-region and bone loss or prostate cancer risk, is
the existence of an unknown, but nearby, gene in
linkage disequilibrium with the VDR polymor-
phisms. However, even the BsmI and poly(A)n var-
iants (which are separated by only about 3 kb of
sequence) are not tightly linked in all ethnic groups
[8]. Therefore, additional work is necessary to de¢ne
the allelic variation that alters the phenotype at this
locus. Only then will we understand the role that
vitamin D plays in prostate cancer risk and bone
metabolism.
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